Over the last 15 years, semaglutide (Ozempic) has been used to treat type 2 diabetes, but has recently been approved by the FDA to help manage weight loss under the brand name Wegovy.

Semaglutide is injected under the skin once weekly with a tiny insulin needle. This medication mimics the hormone GLP-1, which is naturally produced after eating. GLP-1 is responsible for reducing appetite and food cravings while increasing the feeling of fullness.

The majority of patients taking semaglutide lose up to 15% of their body weight, while others could lose more than 20%.